Week of September 5, 2023 | Vol. 12, Issue 35

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Matador

Pharma | Sell-Side

Acquisition opportunity of two sterile injectable ANDAs

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act

US FDA- Aug 2023

As Supply Chain Partners Ramp Up For November DSCSA Deadline, US FDA Gives Them Another Year

Pink Sheet - Aug 28, 2023

Life sciences firm Danaher to buy Abcam in $5.7 bln deal

Reuters - Aug 28, 2023

Resilience Announces Joint Venture with Lifera to Develop Manufacturing Facility in Saudi Arabia

Business Wire - Aug 28, 2023

EUROAPI to acquire BianoGMP to strengthen its CDMO expertise in the high-growth oligonucleotide market

EUROAPI - Aug 29, 2023

US announces first ten drugs up for Medicare price negotiation

Pharmaceutical Technology - Aug 29, 2023

Novo Nordisk Acquires Embark Biotech

Contract Pharma - Aug 31, 2023

Celularity Inks Research Collaboration with Regeneron

Contract Pharma - Sep 1, 2023

Signal: UK clinical research provider Ergomed bought out in $888m deal

Pharmaceutical Technology - Sep 4, 2023

TANNER NEWS

Managing drug shortages: Getting medicines to patients in need

Patients around the world are experiencing drug shortages, with production still recovering from the disruption caused by Covid-19, the war in Ukraine, and rising energy costs. Tanner Pharma is tackling these issues head-on, managing disruptions and ensuring that a range of treatments reach patients wherever they are. Learn more.